Adenosine and atrial fibrillation.
作者信息
Sung R J
出版信息
J Interv Card Electrophysiol. 1997 Feb;1(1):39-40.
PMID:9869949
Abstract
摘要
相似文献
1
Adenosine and atrial fibrillation.腺苷与心房颤动
J Interv Card Electrophysiol. 1997 Feb;1(1):39-40.
2
Dose and rate-dependent effects of adenosine on atrial action potential duration in humans.腺苷对人体心房动作电位时程的剂量和速率依赖性效应。
J Interv Card Electrophysiol. 1997 Feb;1(1):33-7. doi: 10.1023/a:1009758501195.
3
4
Electrophysiologic approach to atrial fibrillation.心房颤动的电生理研究方法
Med Interne. 1979 Oct-Dec;17(4):371-8.
5
Upstream therapy in atrial fibrillation: traveling up the river to find the source.心房颤动的上游治疗：溯流而上探寻源头。
Heart Rhythm. 2010 Apr;7(4):529-30. doi: 10.1016/j.hrthm.2010.02.021. Epub 2010 Feb 18.
6
Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.丹参酮IIA对慢性心力衰竭患者房颤的减少作用
Biomed Pharmacother. 2016 Dec;84:1760-1767. doi: 10.1016/j.biopha.2016.10.110. Epub 2016 Nov 12.
7
[Effects of anti-arrhythmia agents of the heart conduction system].
Nihon Rinsho. 1985 Nov;43(11):2397-403.
8
9
Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.阿普林定对豚鼠心房细胞延迟整流钾电流和毒蕈碱型乙酰胆碱受体激活钾电流的抑制作用。
Br J Pharmacol. 1999 Feb;126(3):751-61. doi: 10.1038/sj.bjp.0702334.
10
Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?心房重构是预防房颤复发的可行靶点吗？
J Cardiovasc Electrophysiol. 2004 Aug;15(8):885-6. doi: 10.1046/j.1540-8167.2004.04325.x.
Zotero 插件